investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Natixis Advisors' Q3-Q4 2022 13F Holdings Comparison: Microsoft Up, Apple Down, and Significant Changes in Other Major Stocks.

Ava Hoppe | 23 April, 2023

Natixis Advisors, L.P. recently released its 13F holdings comparison for Q3 and Q4 of 2022. The report provides a comprehensive overview of the investment portfolio of Natixis Advisors, L.P. indicating the changes in holdings between Q3 and Q4 2022.

One of the most significant changes regarding the holdings of the fund in this period is the increase in shares of Microsoft Corporation (MSFT). The fund increased its shares from 2,910,770 in Q3 to 3,283,841 in Q4, reflecting a 16.2% increase in value. Another major holding, Apple Inc. (AAPL), reported a decline in shares from 3,771,980 to 3,300,353, a decrease of 17.7% in value. Moreover, the fund gained in other crucial stocks such as Visa Inc. (V) and NVIDIA Corporation (NVDA), while losing ground in Amazon.com Inc. (AMZN).

Visa Inc. (V) saw a significant increase in shares from 1,741,109 in Q3 to 1,902,080 in Q4, representing a 27.8% increase in value. The fund also increased its shares in NVidia Corporation (NVDA) from 1,603,607 in Q3 to 1,820,524 in Q4, reflecting a 36.7% increase in value. The gain in shares in these two companies is a reflection of the fund's investment strategy, which prioritizes high-growth stocks with significant upside potential.

On the other hand, Amazon.com Inc. (AMZN) experienced the most significant drop in share value of all the major holdings, with the fund reducing its holdings from 4,298,146 in Q3 to 3,555,942 in Q4, reflecting a 38.5% decline in value. The decrease in shares of Amazon.com Inc. (AMZN) is reflective of the ongoing competition and the need for the company to pivot its strategy towards new growth areas.

The report also shows that the fund reduced its shareholding in popular stocks like Vanguard (VUG), Prologis Inc. (PLD), and The Walt Disney Company (DIS). Vanguard (VUG) witnessed the largest decline in shares, with the fund decreasing its holdings from 1,007,810 in Q3 to 917,902 in Q4, reflecting a decline of 9.3% in value. The reduction in holdings is reflective of the fund's overall strategy to divest from certain positions in favor of higher-growth stocks.

In contrast, some stocks recorded a tremendous increase in shareholding, indicating the fund's willingness to invest in high-risk, high-reward positions. These positions include VSS Vanguard (VSS), which recorded an enormous increase from 1,720,964 in Q3 to 2,654,305 in Q4, reflecting a whopping 70.9% increase in value. Additionally, ISHARES (SCZ) recorded a significant increase in shares from 2,217,351 in Q3 to 3,891,184 in Q4, reflecting a growth of 103.2%.

Also noteworthy is the rise in holdings of several healthcare stocks, including United Health Group Incorporated (UNH), Johnson and Johnson (JNJ), and Eli Lilly & Co (LLY). These holdings reflect the fund's continued investment in the healthcare sector, which has shown resilience in the face of the global pandemic.

In conclusion, the Q3 and Q4 2022 13F Holdings Comparison of Natixis Advisors, L.P. provides insight into the fund's investment strategy and highlights the significant changes in positions over the quarter. Despite the fluctuations in market conditions, the fund has remained focused on high growth and high reward stocks, as well as strategic investments in the healthcare sector.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.